Tempo Therapeutics develops materials that are immune stealth, minimally invasive, and precision-engineered for regenerative medicine.
Tempo Therapeutics's investors include National Science Foundation, Johnson & Johnson, Johnson & Johnson Innovation, Ajax Capital, Galaxy-Sirius Partners.
Tempo Therapeutics is headquartered in San Diego, United States.
Tempo Therapeutics develops materials that are immune stealth, minimally invasive, and precision-engineered for regenerative medicine.
Tempo Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tempo Therapeutics — Funding & Investors." VCBacked, September 12, 2024, https://www.vcbacked.co/company/tempo-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Tempo Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/tempo-therapeutics
{{cite web |title=Tempo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tempo-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated